VRTXCommon stockNASDAQ
VRTX Common stock
This is the ticker-level security page. The issuer is Vertex Pharmaceuticals.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$11.7B
Net income TTM
$3.7B
Total assets
$24.9B
Total debt
Not available
Total equity
$17.3B
Profit margin
31.4%
ROE
21.2%
ROA
14.8%
Latest issuer financial snapshot: 2024-12-31